CYPH
CYPHERPUNK TECHNOLOGIES INC.Company Information
- Company Name
- CYPHERPUNK TECHNOLOGIES INC.
- CIK
- CIK0001509745
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CYPH: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CYPH
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-25
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 1,913,228
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 14,577,523
- Shares outstanding
- 184,328,441
- Ownership
- 7.91%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- 267.78%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 8 | 7 | 14 | 10 | 18 | 33 | 47 | 63 | 78 | 55 | 71 | 81 | ||||||
| Crypto Asset Fair Value Current | 129 | 74 | 147 | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||||||
| Assets Current | 138 | 82 | 162 | 10 | 19 | 34 | 48 | 64 | 80 | 56 | 72 | 82 | ||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | 0 | - | - | - | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||||||
| Deferred Costs | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Deposits Assets Noncurrent | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Long Term Investments | 5 | 5 | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 143 | 87 | 163 | 11 | 20 | 35 | 49 | 65 | 81 | 58 | 73 | 83 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 2 | 4 | 7 | 6 | 5 | 6 | 8 | 6 | 6 | 6 | ||||||
| Accrued Liabilities Current | 1 | 2 | 2 | 4 | 7 | 7 | 9 | 9 | 7 | 4 | 6 | 5 | ||||||
| Taxes Payable Current | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 2 | 3 | 5 | 9 | 14 | 14 | 14 | 16 | 16 | 10 | 13 | 11 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Deferred Income Tax Liabilities Net | 2 | - | 5 | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 4 | 3 | 10 | 9 | - | - | 14 | 16 | 16 | 11 | 13 | 11 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Share Subscribed But Unissued Subscriptions Receivable | - | - | -0 | - | - | - | - | - | - | - | - | - | ||||||
| Additional Paid In Capital | 640 | 624 | 616 | 506 | 505 | 504 | 503 | 501 | 500 | 461 | 460 | 458 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 | 0 | 1 | ||||||
| Retained Earnings Accumulated Deficit | -500 | -540 | -463 | -503 | -499 | -483 | -467 | -452 | -434 | -413 | -400 | -387 | ||||||
| Stockholders Equity | 139 | 84 | 154 | 3 | 6 | 21 | 35 | 49 | 66 | 47 | 60 | 72 | ||||||
| Liabilities And Stockholders Equity | 143 | 87 | 163 | 11 | 20 | 35 | 49 | 65 | 81 | 58 | 73 | 83 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 490 | 490 | 490 | 240 | 240 | 240 | 240 | 240 | 240 | 240 | 240 | 240 | ||||||
| Common Stock Shares Issued | 108 | 94 | 84 | 41 | 41 | 41 | 38 | 38 | 38 | 26 | 26 | 26 | ||||||
| Shares Outstanding | 108 | 94 | 84 | 41 | 41 | 41 | 38 | 38 | 38 | 26 | 26 | 26 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCYPHERPUNK TECHNOLOGIES INC. (CYPH) — SEC Financial Statements & Analysis
CYPHERPUNK TECHNOLOGIES INC. (CYPH) is a pharmaceutical preparations company, incorporated in DE. CYPHERPUNK TECHNOLOGIES INC. trades on Nasdaq as: CYPH. CYPHERPUNK TECHNOLOGIES INC. (CYPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, CYPHERPUNK TECHNOLOGIES INC. carries a market cap of $112.81M, a P/E ratio of -128.63x, a P/B ratio of 0.81x, an enterprise value of $105.19M, and an EV/EBITDA multiple of -5.92x. On profitability, it posts a Return on Equity (ROE) of -1.21%, a Return on Assets (ROA) of -1.08%, and a Return on Invested Capital (ROIC) of 0.00%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.11, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -98.66% year-over-year, and EPS growth of -99.70% year-over-year. On the balance sheet, it maintains a current ratio of 79.19x, a quick ratio of 78.88x, working capital of $135.81M, a debt-to-equity ratio of 0.03x, a debt ratio of 0.03, an interest coverage ratio of -740.63x, free cash flow of $-21.06M (TTM), and net debt of $-7.62M. Figures sourced from SEC EDGAR.
- Market Cap
- $112.81M
- P/E TTM
- -128.63x
- EPS TTM
- $-0.00
- P/B TTM
- 0.81x
- ROE TTM
- -1.21%
- ROA TTM
- -1.08%
- Debt To Equity
- 0.03x
- Free Cash Flow TTM
- $-21.06M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CYPHERPUNK TECHNOLOGIES INC. in?
CYPHERPUNK TECHNOLOGIES INC. (CYPH) operates in the Pharmaceutical Preparations industry.
What exchange does CYPH trade on?
CYPHERPUNK TECHNOLOGIES INC. (CYPH) trades on the Nasdaq.
Where is CYPHERPUNK TECHNOLOGIES INC. incorporated?
CYPHERPUNK TECHNOLOGIES INC. is incorporated in DE.
When was CYPHERPUNK TECHNOLOGIES INC. (CYPH)'s most recent SEC filing?
CYPHERPUNK TECHNOLOGIES INC. (CYPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is CYPH's market cap?
CYPHERPUNK TECHNOLOGIES INC. (CYPH) has a market capitalization of $112.81M as of 2026-06-30.
What is CYPH's EPS (earnings per share)?
CYPHERPUNK TECHNOLOGIES INC. (CYPH)'s trailing twelve month EPS is $-0.00 as of 2026-06-30.
What is CYPH's ROE (return on equity)?
CYPHERPUNK TECHNOLOGIES INC. (CYPH)'s trailing twelve month Return on Equity (ROE) is -1.21% as of 2026-06-30.
What is CYPH's ROA (return on assets)?
CYPHERPUNK TECHNOLOGIES INC. (CYPH)'s trailing twelve month Return on Assets (ROA) is -1.08% as of 2026-06-30.
What is CYPH's ROIC (return on invested capital)?
CYPHERPUNK TECHNOLOGIES INC. (CYPH)'s trailing twelve month Return on Invested Capital (ROIC) is 0.00% as of 2026-06-30.
What is CYPH's EV/EBITDA?
CYPHERPUNK TECHNOLOGIES INC. (CYPH)'s trailing twelve month EV/EBITDA is -5.92x as of 2026-06-30.